Literature DB >> 4833608

Polyadenylate sequences on Newcastle disease virus mRNA synthesized in vivo and in vitro.

S R Weiss, M A Bratt.   

Abstract

Polyadenylate [poly(A)] sequences are associated with the 35 and 50S Newcastle disease virus (NDV)-specific RNAs as well as all six to seven of the 18-22S NDV-specific messenger RNAs extracted from infected chicken embryo cells. The poly(A) associated with the 18-22S RNA has an average size of 120 to 130 nucleotides. The 18-22S RNA synthesized in vitro by NDV's virion-bound polymerase contains six to seven species of the same size and relative proportions as its intracellular counterpart. This in vitro synthesized 18-22S RNA also contains covalently linked poly(A) sequences which, although variable in size, are usually larger and more heterogeneous than those from the infected cell. In vitro RNA synthesis is supported not only by magnesium (at an optimal concentration of mM) but by manganese (at an optimal concentration of 0.5 to 1.0 mM) as well. However, the major product made in the presence of manganese, although sedimenting at 18 to 22S, differs somewhat from the product made in the presence of magnesium.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4833608      PMCID: PMC355441     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Ribonucleic acid synthesis of vesicular stomatitis virus. 3. Multiple complementary messenger RNA molecules.

Authors:  A S Huang; D Baltimore; M Stampfer
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

2.  Replication of Sendai virus. II. Steps in virus assembly.

Authors:  C D Blair; W S Robinson
Journal:  J Virol       Date:  1970-05       Impact factor: 5.103

3.  Replication of Sendai virus. I. Comparison of the viral RNA and virus-specific RNA synthesis with Newcastle disease virus.

Authors:  C D Blair; W S Robinson
Journal:  Virology       Date:  1968-08       Impact factor: 3.616

4.  Evidence for an RNA replicative intermediate in cells infected with Newcastle disease virus.

Authors:  M A Bratt; W S Robinson
Journal:  J Gen Virol       Date:  1971-02       Impact factor: 3.891

5.  RNA synthesis in chick embryo cells infected with different strains of NDV.

Authors:  M A Bratt
Journal:  Virology       Date:  1969-07       Impact factor: 3.616

6.  Preliminary analysis of the requirements for fusion from within and fusion from without by Newcastle disease virus.

Authors:  M A Bratt; W R Gallaher
Journal:  Proc Natl Acad Sci U S A       Date:  1969-10       Impact factor: 11.205

7.  Newcastle disease virus RNA. I. Isolation and preliminary characterization of RNA from virus particles.

Authors:  D W Kingsbury
Journal:  J Mol Biol       Date:  1966-06       Impact factor: 5.469

8.  Isolation of the nucleic acid of Newcastle disease virus (NDV).

Authors:  P H Duesberg; W S Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  1965-09       Impact factor: 11.205

9.  Transcription of the influenza ribonucleic acid genome by a virion polymerase. I. Optimal conditions for in vitro activity of the ribonucleic acid-dependent ribonucleic acid polymerase.

Authors:  D H Bishop; J F Obijeski; R W Simpson
Journal:  J Virol       Date:  1971-07       Impact factor: 5.103

10.  Polyadenylic acid sequences: role in conversion of nuclear RNA into messenger RNA.

Authors:  J E Darnell; L Philipson; R Wall; M Adesnik
Journal:  Science       Date:  1971-10-29       Impact factor: 47.728

View more
  32 in total

1.  Effect of cordycepin (3'-deoxyadenosine) on virus-specific RNA species synthesized in Newcastle disease virus-infected cells.

Authors:  S R Weiss; M A Bratt
Journal:  J Virol       Date:  1975-12       Impact factor: 5.103

2.  Newcastle disease virus-specific RNA: poly(A)-containing and poly(A)-deficient transcripts as revealed by chromatography on poly(U)-sepharose.

Authors:  N L Varich; I S Lukashevich; N V Kaverin
Journal:  J Virol       Date:  1976-04       Impact factor: 5.103

3.  Neutralization map of the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus: domains recognized by monoclonal antibodies that prevent receptor recognition.

Authors:  R M Iorio; R J Syddall; J P Sheehan; M A Bratt; R L Glickman; A M Riel
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

4.  Isolation and preliminary characterization of temperature-sensitive mutants of Newcastle disease virus.

Authors:  J E Tsipis; M A Bratt
Journal:  J Virol       Date:  1976-06       Impact factor: 5.103

5.  Selection of unique antigenic variants of Newcastle disease virus with neutralizing monoclonal antibodies and anti-immunoglobulin.

Authors:  R M Iorio; M A Bratt
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

6.  Quantitative basic residue requirements in the cleavage-activation site of the fusion glycoprotein as a determinant of virulence for Newcastle disease virus.

Authors:  R L Glickman; R J Syddall; R M Iorio; J P Sheehan; M A Bratt
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

7.  Isolation of a transcriptive complex from Newcastle disease virions.

Authors:  R J Colonno; H O Stone
Journal:  J Virol       Date:  1976-09       Impact factor: 5.103

8.  Influenza virion transcriptase: synthesis in vitro of large, polyadenylic acid-containing complementary RNA.

Authors:  S J Plotch; R M Krug
Journal:  J Virol       Date:  1977-01       Impact factor: 5.103

9.  Structural and functional characterization of Newcastle disease virus polycistronic RNA species.

Authors:  A Wilde; T Morrison
Journal:  J Virol       Date:  1984-07       Impact factor: 5.103

10.  UV irradiation analysis of complementation between, and replication of, RNA-negative temperature-sensitive mutants of Newcastle disease virus.

Authors:  M E Peeples; M A Bratt
Journal:  J Virol       Date:  1982-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.